Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 2Pituitary Neoplasms 1Pain 1Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Hemorrhage 1Haloperidol 1Growth Hormone-Secreting Pituitary Adenoma 1Brain Neoplasms 1Anemia 1Acromegaly 1

Interventions

Solutions 1Haloperidol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Haloperidol × Solutions × Clear all
NCT04833023 2024-04-12

HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial

Tan Tock Seng Hospital

Phase 3 Unknown
72 enrolled

Haloperidol

Data powered by HemOnc (CC BY 4.0) Colophon âš¡